Читать книгу Clinical Cases in Periodontics - Группа авторов - Страница 88

1 1. Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions. Introduction and key changes from the 1999 classification. J Periodontol 2018; 89(Suppl 1):S1–S8.

2 2. De Boever AL, Quirynen M, Coucke W, et al. Clinical and radiographic study of implant treatment outcome in periodontally susceptible and non-susceptible patients: a prospective long-term study. Clin Oral Implants Res 2009; 20:1341–1350.

3 3. Al-Zahrani MS. Implant therapy in aggressive periodontitis patients: a systematic review and clinical implications. Quintessence Int 2008; 39:211–215.

4 4. Meng H, Xu L, Li Q, et al. Determinants of host susceptibility in aggressive periodontitis. Periodontol 2000 2007; 43:133–159.

5 5. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4:1–6.

6 6. Brown LJ, Albandar JM, Brunelle JA, Loe H. Early-onset periodontitis: progression of attachment loss during 6 years. J Periodontol 1996; 67:968–975.

7 7. Orban B. A diffuse atrophy of the alveolar bone (periodontosis). J Periodontol 1942; 13:31.

8 8. Baer PN. The case for periodontosis as a clinical entity. J Periodontol 1971; 42:516–520.

9 9. Lang N, Bartold PM, Cullinan M, et al. Consensus report: aggressive periodontitis. Ann Periodontol 1999; 4:53.

10 10. Benjamin SD, Baer PN. Familial patterns of advanced alveolar bone loss in adolescence (periodontosis). Periodontics 1967; 5:82–88.

11 11. Kantarci A, Oyaizu K, Van Dyke TE. Neutrophil‐mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 2003; 74:66–75.

12 12. Fredman G, Oh SF, Ayilavarapu S, et al. Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One 2011; 6:e24422.

13 13. Shaddox L, Wiedey J, Bimstein E, et al. Hyper‐responsive phenotype in localized aggressive periodontitis. J Dent Res 2010; 89:143–148.

14 14. Fine DH, Armitage GC, Genco RJ, et al. Unique etiologic, demographic, and pathologic characteristics of localized aggressive periodontitis support classification as a distinct subcategory of periodontitis. J Am Dent Assoc 2019; 150:922–931.

15 15. Loe H, Brown LJ. Early onset periodontitis in the United States of America. J Periodontol 1991; 62:608–616.

16 16. Albandar JM, Muranga MB, Rams TE. Prevalence of aggressive periodontitis in school attendees in Uganda. J Clin Periodontol 2002; 29:823–831.

17 17. Miller K, Treloar T, Guelmann M, et al. Clinical characteristics of localized aggressive periodontitis in primary dentition. J Clin Pediatr Dent 2018; 42:95–102.

18 18. Merchant SN, Vovk A, Kalash D, et al. Localized aggressive periodontitis treatment response in primary and permanent dentitions. J Periodontol 2014; 85:1722–1729.

19 19. Marazita ML, Burmeister JA, Gunsolley JC, et al. Evidence for autosomal dominant inheritance and race‐specific heterogeneity in early‐onset periodontitis. J Periodontol 1994; 65:623–630.

20 20. Hart TC, Marazita ML, Schenkein HA, Diehl SR. Re‐interpretation of the evidence for X‐linked dominant inheritance of juvenile periodontitis. J Periodontol 1992; 63:169–173.

21 21. Fine DH, Markowitz K, Furgang D, et al. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 2007; 45:3859–3869.

22 22. Haraszthy VI, Hariharan G, Tinoco EM, et al. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early‐onset periodontitis. J Periodontol 2000; 71:912–922.

23 23. Fine DH, Markowitz K, Fairlie K, et al. A consortium of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is present in sites prior to bone loss in a longitudinal study of localized aggressive periodontitis. J Clin Microbiol 2013; 51:2850–2861.

24 24. Fine DH, Markowitz K, Fairlie K, et al. Macrophage inflammatory protein‐1α shows predictive value as a risk marker for subjects and sites vulnerable to bone loss in a longitudinal model of aggressive periodontitis. PLoS One 2014; 9:e98541.

25 25. Faveri M, Figueiredo LC, Duarte PM, et al. Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol 2009; 36:739–749.

26 26. Zambon JJ, Christersson LA, Slots J. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. J Periodontol 1983; 54:707–711.

27 27. Ebersole JL, Cappelli D, Steffen MJ. Antigenic specificity of gingival crevicular fluid antibody to Actinobacillus actinomycetemcomitans. J Dent Res 2000; 79:1362–1370.

28 28. Teughels W, Dhondt R, Dekeyser C, Quirynen M. Treatment of aggressive periodontitis. Periodontol 2000 2014; 65:107–133.

29 29. Miller KA, Branco‐de‐Almeida LS, Wolf S, et al. Long‐term clinical response to treatment and maintenance of localized aggressive periodontitis: a cohort study. J Clin Periodontol 2017; 44:158–168.

30 30. Gorski B, Jalowski S, Gorska R, Zaremba M. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 12‐month randomized controlled trial. Clin Oral Investig 2018; 22:2819–2828.

31 31. Artzi Z, Sudri S, Platner O, Kozlovsky A. Regeneration of the periodontal apparatus in aggressive periodontitis patients. Dent J (Basel) 2019; 7(1):29.

32 32. Momen‐Heravi F, Kang P. Treatment of localized aggressive periodontitis with guided tissue regeneration technique and enamel matrix derivative. Clin Adv Periodontics 2017; 7:182–189.

33 33. Pavicic MJ, van Winkelhoff AJ, Douque NH, et al. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans‐associated periodontitis. A 2‐year evaluation. J Clin Periodontol 1994; 21:107–112.

34 34. Winkel EG, van Winkelhoff AJ, van der Velden U. Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy. J Clin Periodontol 1998; 25:857–864.

35 35. Buchmann R, Nunn ME, Van Dyke TE, Lange DE. Aggressive periodontitis: 5‐year follow‐up of treatment. J Periodontol 2002; 73:675–683.

36 36. Kamma JJ, Baehni PC. Five‐year maintenance follow‐up of early‐onset periodontitis patients. J Clin Periodontol 2003; 30:562–572.

37 37. Baumer A, Weber D, Staufer S, et al. Tooth loss in aggressive periodontitis: results 25 years after active periodontal therapy in a private practice. J Clin Periodontol 2020; 47(2):223–232.

38 38. Petit C, Huck O, Amar S, Tenenbaum H. Management of localized aggressive periodontitis: a 30‐year follow‐up. Quintessence Int 2018; 49:615–624.

39 39. Mros ST, Berglundh T. Aggressive periodontitis in children: a 14–19‐year follow‐up. J Clin Periodontol 2010; 37:283–287.

40 40. Dopico J, Nibali L, Donos N. Disease progression in aggressive periodontitis patients. A retrospective study. J Clin Periodontol 2016; 43:531–537.

41 41. Goh V, Nihalani D, Yeung KWS, et al. Moderate‐ to long‐term therapeutic outcomes of treated aggressive periodontitis patients without regular supportive care. J Periodontal Res 2018; 53:324–333.

42 42. Kaner D, Bernimoulin JP, Kleber BM, Friedmann A. Minimally invasive flap surgery and enamel matrix derivative in the treatment of localized aggressive periodontitis: case report. Int J Periodontics Restorative Dent 2009; 29:89–97.